RedShiftBio Product Launch PEGS 2018
Schedule a meeting with our team
Following the closing of last year’s $11 Million Series C equity financing, RedShiftBio is excited to announce the launch of an IR instrument at PEGS. The instrument is powered by a new sensing technology called Microfluidic Modulation Spectroscopy, allowing you to see change in protein characterization that is not possible today. Participants in last year’s equity financing included Waters Corporation (NYSE: WAT), the world's leading specialty measurement company in the development and manufacture of innovative analytical solutions, and Technology Venture Partners, a venture capital firm specializing in technology and healthcare. Both Waters and RedShiftBio are hosting many events at PEGS.
Come meet with us during the conference:
Anders Lund, PhD, Scientific Director, Bioanalytics Characterization Group, BioPharmaceutics Development, Sanofi
Lessons from the Development and Execution of an Automated Purification, Digestion, and Targeted LCMS Analysis (MAM) of Biotherapeutics
RedShiftBio Happy Hour on booth #316. Come and learn about a new technique for measuring Aggregation, Quantitation, Structure, Similarity, and Stability in one single analyzer.
Product Launch Presentation
RedShiftBio Product Launch Presentation in the Theatre Area of the main exhibit hall. Hear RedShiftBio CTO, Eugene Ma, showcase the Microfludic Modulation Spectroscopy Analyzer and case studies from a few of our many collaborators.